• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮中的HLA抗原:与疾病严重程度、发病年龄及性别的关系

HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.

作者信息

Bell D A, Rigby R, Stiller C R, Clark W F, Harth M, Ebers G

出版信息

J Rheumatol. 1984 Aug;11(4):475-9.

PMID:6332909
Abstract

Sixty-two Caucasian patients with systemic lupus erythematosus (SLE) were studied to determine whether any significant clinical correlations existed with various HLA antigens. While HLA-B8 and DR3 were significantly increased among the SLE population in general, these or other HLA antigens did not correlate with the severity of renal disease. HLA-B8 was significantly higher only in SLE males compared to male controls. The age of onset of disease in females was clustered into 2 groups, one with early age of onset (mean = 21.6 years, range 12-32 years) and another with later age of onset (mean = 48 years; range 38-60 years). SLE females with later age of onset showed an increased frequency of HLA-DR3 compared to sex and age matched controls, while those with early onset SLE showed no significant increase in any HLA antigens. Therefore any risk conferred by the presence of genes associated with HLA-B8 or DR3 is significant only in SLE males and SLE females whose disease onset was over the age of 35. Despite the greater frequency of HLA-B8, DR3 in SLE females with later onset of disease, this group did not have a greater frequency of anti-Ro antibodies compared to females with early age onset of SLE.

摘要

对62名患有系统性红斑狼疮(SLE)的白种人患者进行了研究,以确定各种HLA抗原是否存在任何显著的临床相关性。虽然总体上SLE人群中HLA - B8和DR3显著增加,但这些或其他HLA抗原与肾脏疾病的严重程度无关。与男性对照组相比,仅SLE男性中的HLA - B8显著更高。女性疾病的发病年龄分为两组,一组发病年龄较早(平均 = 21.6岁,范围12 - 32岁),另一组发病年龄较晚(平均 = 48岁;范围38 - 60岁)。与性别和年龄匹配的对照组相比,发病年龄较晚的SLE女性中HLA - DR3的频率增加,而发病早的SLE女性中任何HLA抗原均无显著增加。因此,与HLA - B8或DR3相关基因的存在所带来的任何风险仅在发病年龄超过35岁的SLE男性和SLE女性中显著。尽管发病较晚的SLE女性中HLA - B8、DR3的频率更高,但与发病早的SLE女性相比,该组抗Ro抗体的频率并没有更高。

相似文献

1
HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.系统性红斑狼疮中的HLA抗原:与疾病严重程度、发病年龄及性别的关系
J Rheumatol. 1984 Aug;11(4):475-9.
2
HLA-B8 in caucasian patients with systemic lupus erythematosus.白种人系统性红斑狼疮患者中的HLA - B8
Scand J Rheumatol. 1978;7(1):3-6.
3
Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.主要组织相容性复合体I类链相关A(MICA)基因多态性对系统性红斑狼疮遗传易感性的贡献。
Rheumatology (Oxford). 2005 Mar;44(3):287-92. doi: 10.1093/rheumatology/keh459. Epub 2004 Nov 2.
4
A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.系统性红斑狼疮疾病异质性模型。组织相容性抗原、自身抗体与淋巴细胞减少或肾脏疾病之间的关系。
Arthritis Rheum. 1989 Jul;32(7):826-36.
5
[Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].HLA - B8与系统性红斑狼疮及特定血清学标志物的显著关联
Dtsch Med Wochenschr. 1987 Apr 10;112(15):577-80. doi: 10.1055/s-2008-1068100.
6
[Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].[西班牙南部系统性红斑狼疮患者的I类和II类人类白细胞抗原]
Med Clin (Barc). 1994 May 14;102(18):688-93.
7
Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.意大利北部DR抗原、伴或不伴有关节外表现的类风湿关节炎与系统性红斑狼疮之间的关联。
J Rheumatol. 1988 Jan;15(1):51-3.
8
A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.系统性红斑狼疮与肿瘤坏死因子α之间的基因关联。
Eur J Immunol. 1994 Jan;24(1):191-5. doi: 10.1002/eji.1830240130.
9
HLA antigens associated with systemic lupus erythematosus in Japan.日本与系统性红斑狼疮相关的人类白细胞抗原
J Rheumatol. 1985 Oct;12(5):919-23.
10
Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype.
Exp Clin Immunogenet. 1992;9(2):72-9.

引用本文的文献

1
A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.迟发性与早发性系统性红斑狼疮皮肤表现的系统评价和荟萃分析。
Semin Arthritis Rheum. 2016 Jun;45(6):691-7. doi: 10.1016/j.semarthrit.2016.01.004. Epub 2016 Jan 21.
2
Disease Expression and HLA Types in Early and Late Onset Disease of Malaysian Patients with Systemic Lupus Erythematosus.马来西亚系统性红斑狼疮患者早发型和晚发型疾病中的疾病表现及人类白细胞抗原类型
Malays J Med Sci. 2001 Jul;8(2):32-9.
3
Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.
系统性红斑狼疮患者谷胱甘肽S-转移酶基因型与脉冲环磷酰胺治疗副作用的关系
Br J Clin Pharmacol. 2006 Oct;62(4):457-72. doi: 10.1111/j.1365-2125.2006.02690.x.
4
HLA antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression.马来西亚系统性红斑狼疮患者的人类白细胞抗原(HLA)抗原:与临床及自身抗体表达的关联
Korean J Intern Med. 2001 Jun;16(2):123-31. doi: 10.3904/kjim.2001.16.2.123.
5
Occupational exposure to crystalline silica and autoimmune disease.职业性接触结晶硅石与自身免疫性疾病
Environ Health Perspect. 1999 Oct;107 Suppl 5(Suppl 5):793-802. doi: 10.1289/ehp.99107s5793.
6
Systemic lupus erythematosus clinical issues.系统性红斑狼疮的临床问题。
Springer Semin Immunopathol. 1986;9(2-3):251-70. doi: 10.1007/BF02099025.
7
Evidence that autoimmunity in man is a Mendelian dominant trait.人类自身免疫是孟德尔显性性状的证据。
Am J Hum Genet. 1986 Nov;39(5):584-602.
8
HLA-A, B antigens and alpha 1-antitrypsin phenotypes in nodal generalised osteoarthritis and erosive osteoarthritis.结节性全身性骨关节炎和侵蚀性骨关节炎中的HLA - A、B抗原及α1 -抗胰蛋白酶表型
Ann Rheum Dis. 1989 Jun;48(6):470-5. doi: 10.1136/ard.48.6.470.
9
Neurogenic bladder due to peripheral neuropathy and a visual disturbance in an elderly man with systemic lupus erythematosus.一名患有系统性红斑狼疮的老年男性因周围神经病变导致神经源性膀胱及视力障碍。
Ann Rheum Dis. 1992 Apr;51(4):547-9. doi: 10.1136/ard.51.4.547.